Last reviewed · How we verify

XENON XE 133 — Competitive Intelligence Brief

XENON XE 133 (XENON XE 133) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inhalation Diagnostic Agent [EPC].

marketed Inhalation Diagnostic Agent [EPC] Small molecule Live · refreshed every 30 min

Target snapshot

XENON XE 133 (XENON XE 133).

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
XENON XE 133 TARGET XENON XE 133 marketed Inhalation Diagnostic Agent [EPC] 1982-01-01
Xe 127 xenon (127Xe) gas marketed Inhalation Diagnostic Agent 1982-01-01
Xe 133 xenon (133Xe) gas Mallinckrodt marketed Inhalation Diagnostic Agent [EPC]

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inhalation Diagnostic Agent [EPC] class)

  1. · 1 drug in this class
  2. Mallinckrodt · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). XENON XE 133 — Competitive Intelligence Brief. https://druglandscape.com/ci/xenon-xe-133. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: